Consensus Ridgepost Capital, Inc

Stocks

RPC

US69376K1060

Investment Management & Fund Operators

Market Closed - NYSE 16:00:02 2026-09-21 EDT			5-day change	1st Jan Change
7.890 ^USD	+0.25%		-1.99%	-19.57%

08-27	Oppenheimer Adjusts Price Target on Ridgepost Capital to $15 From $16, Keeps Outperform Rating	MT
08-07	Tranche Update on Ridgepost Capital, Inc's Equity Buyback Plan announced on May 12, 2022.	CI

Evolution of the Average Target: Ridgepost Capital, Inc

Evolution of the Target Price: Ridgepost Capital, Inc

Changes in Analyst Recommendations: Ridgepost Capital, Inc

3a18094d6243991810bb1c.9aVIZvX_4sgBf2RNsdk5ot8RVdqD-NM-nPCoQv8K6P4.nuoGMLi6tK1PNFck8IMNyr5iBZzwlZdK2cbvJMZopKqE5HsQrKy3mVZGXA~057081faff75dd138241d401d78b080c

Analysts' recommendations: Ridgepost Capital, Inc

08-27	Oppenheimer Adjusts Price Target on Ridgepost Capital to $15 From $16, Keeps Outperform Rating	MT
08-06	Oppenheimer Adjusts PT on Ridgepost Capital to $16 From $17, Maintains Outperform Rating	MT
04-13	Oppenheimer Adjusts Ridgepost Capital Price Target to $16 From $24, Maintains Outperform Rating	MT
25-05-15	Oppenheimer Lifts Price Target on P10 to $20 From $19, Keeps Outperform Rating	MT
25-05-12	Oppenheimer Adjusts P10 Price Target to $19 From $18, Maintains Outperform Rating	MT
25-01-07	JPMorgan Upgrades P10 to Overweight From Neutral, Adjusts Price Target to $15 From $14	MT
24-12-12	Oppenheimer Adjusts Price Target on P10 to $21 From $17, Maintains Outperform Rating	MT
24-11-13	UBS Raises Price Target on P10 to $13 From $12, Maintains Neutral Rating	MT
24-10-22	UBS Adjusts P10 Price Target to $12 From $10.50, Maintains Neutral Rating	MT
24-10-16	Oppenheimer Adjusts P10 Price Target to $16 From $13, Maintains Outperform Rating	MT
24-08-21	UBS Downgrades P10 to Neutral From Buy, Raises Price Target to $10.50 From $10	MT
24-08-12	P10 Outperformed Expectations in Q2 With Strong Fees, Shares Undervalued, Oppenheimer Says	MT
24-07-08	Oppenheimer Adjusts Price Target on P10 to $13 From $12, Maintains Outperform Rating	MT
24-04-12	Oppenheimer Adjusts P10 Price Target to $12 From $11, Maintains Outperform Rating	MT
24-03-04	Barclays Adjusts Price Target on P10 to $9.50 From $14, Maintains Overweight Rating	MT
24-03-04	Morgan Stanley Downgrades P10 to Equalweight From Overweight, Price Target is $9	MT
24-03-04	Oppenheimer Adjusts P10 Price Target to $11 From $17, Maintains Outperform Rating	MT
24-03-01	JPMorgan Downgrades P10 to Neutral From Overweight, Cuts Price Target to $9.50 From $15.50	MT
24-03-01	Keefe Bruyette & Woods Downgrades P10 to Market Perform From Outperform, Adjusts Price Target to $10 From $12	MT
24-01-11	Oppenheimer Adjusts P10 Price Target to $17 From $15, Maintains Outperform Rating	MT
23-11-10	Stephens Trims Price Target on P10 to $15 From $16, Keeps Overweight Rating	MT
23-10-20	UBS Adjusts P10 Price Target to $13.50 From $14.50, Maintains Buy Rating	MT
23-10-18	Morgan Stanley Adjusts Price Target on P10 to $13 From $14, Maintains Overweight Rating	MT
23-10-09	Oppenheimer Trims P10's Price Target to $15 From $16, Keeps Outperform Rating	MT
23-08-16	UBS Adjusts P10 Price Target to $14.50 From $12, Maintains Buy Rating	MT